CGON — CG Oncology, Inc.
6 mentions in the last 24 hours · 0.02% of all mentions
Why people talked about CGON (2026-11-06)
- CG Oncology reported Q3 2026 financial results, with EPS of -$0.64 beating estimates.
- Revenue reached $1.6M, exceeding estimates by 149.2% despite a year-over-year decline.
- The company issued a press release on November 6, 2026, detailing results for the quarter ended September 30, 2026.
| Bluesky | 4 | community |
| GDELT | 1 | news |
| SEC EDGAR 8-K | 1 | filings |